Due Diligence and Art

Due Diligence and Art

Clinical Trials in the UK are Down by 44% Primarily Due to Lack of Participants

The public trust in pharma is vanishing. This is good news.

Sasha Latypova's avatar
Sasha Latypova
Mar 02, 2023
∙ Paid

According to a recent article by Endpoints News, the clinical trials industry in the UK is in shambles:

From 2017 to 2021, there was a 44% drop in recruitment of patients to commercial clinical trials and a 48% decline in the number of Phase III industry trials initiated in the UK. The UK fell in global ranking from fourth in 2017 for Phase III industry …

User's avatar

Continue reading this post for free, courtesy of Sasha Latypova.

Or purchase a paid subscription.
© 2026 Sasha Latypova · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture